Lancet Hiv

Journal Title：Lancet Hiv

The Lancet HIV launched in September 2014 as an exclusively online journal, publishing original research, expert commentary, informative editorials, and timely correspondence. The monthly journal provides readers with context and insight into the clinical advances and practice-changing research shaping the study of HIV/AIDS today.

Now is a critical moment in the fight against HIV/AIDS. Despite the world view that the end of AIDS may be within reach, the job of controlling this epidemic is certainly not done. As HIV disease evolves to become a chronic infection, the interaction of the virus with other chronic conditions will present a host of new challenges. The Lancet HIV is a journal for a new era in the history of HIV/AIDS.

The Lancet HIV builds on The Lancet journals' reputation for publishing HIV/AIDS research to provide a reliable foundation for advocacy and for programmatic and political change. We will consider clinical, epidemiological, operational, and implementation research, unifying these disciplines across a single vision for the health of those living with HIV.

《柳叶刀艾滋病》于 2014 年 9 月作为一本纯在线期刊推出，发表原创研究、专家评论、信息丰富的社论和及时的通讯。该月刊为读者提供有关临床进展和改变实践的研究的背景和见解，这些研究正在影响当今的艾滋病研究。

现在是抗击艾滋病的关键时刻。尽管世界认为艾滋病的终结可能触手可及，但控制这一流行病的工作肯定尚未完成。随着艾滋病发展成为慢性感染，病毒与其他慢性疾病的相互作用将带来许多新挑战。《柳叶刀艾滋病》是一本开创艾滋病历史新纪元的期刊。

《柳叶刀艾滋病》以《柳叶刀》期刊发表艾滋病研究的声誉为基础，为宣传以及计划和政治变革提供了可靠的基础。我们将考虑临床、流行病学、操作和实施研究，将这些学科统一为艾滋病毒感染者的健康愿景。

Lancet Hiv创刊于2014年，由Elsevier Ltd出版商出版，收稿方向涵盖IMMUNOLOGYINFECTIOUS DISEASES& - INFECTIOUS DISEASES全领域，在行业领域中学术影响力很大，属于TOP期刊，国际一流期刊，关注度和专业度非常高，所以对原创文章要求创新性很高，过审难度很高，如果您有志于TOP期刊，建议关注此刊。平均审稿速度 ，影响因子指数12.8，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。